12OBJECTIVE: Chronic graft-vs-host disease (GVHD) has certain similarities with autoimmune diseases and is associated with the development of various autoantibodies in some patients. In this study, we analyzed the occurrence of autoantibodies in 63 patients surviving longer than 3 months after an allogeneic haematopoietic stem cell transplantation (HSCT), with the aim of detecting a possible association between occurrence of autoantibodies and development of chronic GVHD and immune recovery after HSCT. PATIENTS AND METHODS: The patients were screened every 3 months for the occurrence of the following autoantibodies: anti-nuclear (ANA), anti-mitochondrial (AMA), anti-smooth muscle (ASMA), anti-cardiolipin (ACLA), anti-liver-kidney microsoma...
Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell tr...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for hematologic malig...
OBJECTIVE: Chronic graft-vs-host disease (GVHD) has certain similarities with autoimmune diseases an...
Manifestations of autoimmune diseases are common in patients who have received allogeneic bone marro...
Chronic graft-versus-host disease is a serious complication in long-term survivors of allogeneic hem...
International audienceBACKGROUND: Use of a reduced-intensity conditioning regimen before an allogene...
Primary biliary cirrhosis (PBC) and graft-versus-host disease (GVHD) are thought to have common immu...
For months to years after haematopoietic stem cell transplant (HSCT), recipients may experience immu...
Hematopoietic stem cell transplantation (HSCT) can either cause or eliminate autoimmune disease. Her...
Hematopoietic stem cell transplantation (HSCT) can either cause or eliminate autoimmune disease. Her...
Aim: Identify in literature the graft versus host disease (GVHD) incidence after autologous hematopo...
International audienceFollowing allogenic hematopoietic stem cell transplantation (HSCT), patients w...
Autoimmune hemolytic anemia (AIHA) is a recognized complication of hematopoietic stem cell transplan...
Autoimmune hemolytic anemia (AIHA) is a recognized complication of hematopoietic stem cell transplan...
Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell tr...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for hematologic malig...
OBJECTIVE: Chronic graft-vs-host disease (GVHD) has certain similarities with autoimmune diseases an...
Manifestations of autoimmune diseases are common in patients who have received allogeneic bone marro...
Chronic graft-versus-host disease is a serious complication in long-term survivors of allogeneic hem...
International audienceBACKGROUND: Use of a reduced-intensity conditioning regimen before an allogene...
Primary biliary cirrhosis (PBC) and graft-versus-host disease (GVHD) are thought to have common immu...
For months to years after haematopoietic stem cell transplant (HSCT), recipients may experience immu...
Hematopoietic stem cell transplantation (HSCT) can either cause or eliminate autoimmune disease. Her...
Hematopoietic stem cell transplantation (HSCT) can either cause or eliminate autoimmune disease. Her...
Aim: Identify in literature the graft versus host disease (GVHD) incidence after autologous hematopo...
International audienceFollowing allogenic hematopoietic stem cell transplantation (HSCT), patients w...
Autoimmune hemolytic anemia (AIHA) is a recognized complication of hematopoietic stem cell transplan...
Autoimmune hemolytic anemia (AIHA) is a recognized complication of hematopoietic stem cell transplan...
Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell tr...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for hematologic malig...